Cargando…
Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer
BACKGROUND: Recent studies have demonstrated that microRNA-22 (miR-22) was deregulated in many types of cancers and was involved in various cellular processes related to carcinogenesis. However, the clinical significance and prognostic value of miR-22 in epithelial ovarian cancer (EOC) haven’t been...
Autores principales: | Wan, Wei-na, Zhang, Yu-qin, Wang, Xue-mei, Liu, Yan-jun, Zhang, Yi-xia, Que, Yan-hong, Zhao, Wen-jing, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180346/ https://www.ncbi.nlm.nih.gov/pubmed/25257702 http://dx.doi.org/10.1186/s13000-014-0178-8 |
Ejemplares similares
-
SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
por: Zhang, Peng-Fei, et al.
Publicado: (2019) -
Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer
por: Zhang, Ruitao, et al.
Publicado: (2021) -
Down-regulation of miR-338-3p and Up-regulation of MACC1 Indicated Poor Prognosis of Epithelial Ovarian Cancer Patients
por: Zhang, Ruitao, et al.
Publicado: (2019) -
Down-regulated miR-9 and miR-433 in human gastric carcinoma
por: Luo, Hongchun, et al.
Publicado: (2009) -
miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)